Free Trial

GM Advisory Group LLC Acquires New Shares in Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • GM Advisory Group LLC has acquired 9,035 shares of Astera Labs, Inc. (NASDAQ:ALAB), valued at approximately $539,000, marking a new position in the company's stock.
  • Astera Labs reported a 149.5% year-over-year revenue increase, achieving $191.93 million in revenue for the most recent quarter and beating earnings estimates with an EPS of $0.44.
  • Recent analyst ratings show a general optimism for Astera Labs, with several analysts boosting their price targets, including Evercore ISI raising it to $215.00, highlighting the company's growth potential in the AI infrastructure market.
  • Want stock alerts on Astera Labs? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

GM Advisory Group LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 9,035 shares of the company's stock, valued at approximately $539,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Astera Labs by 2,824.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock valued at $20,467,000 after acquiring an additional 149,240 shares in the last quarter. Aigen Investment Management LP raised its holdings in shares of Astera Labs by 50.9% during the first quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock valued at $1,069,000 after acquiring an additional 6,045 shares in the last quarter. Pacific Point Advisors LLC raised its holdings in shares of Astera Labs by 75.0% during the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock valued at $418,000 after acquiring an additional 3,000 shares in the last quarter. Oppenheimer Asset Management Inc. raised its holdings in shares of Astera Labs by 73.6% during the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock valued at $954,000 after acquiring an additional 6,783 shares in the last quarter. Finally, Taylor Frigon Capital Management LLC bought a new position in shares of Astera Labs during the first quarter valued at approximately $1,887,000. Institutional investors own 60.47% of the company's stock.

Insider Transactions at Astera Labs

In other news, CFO Michael Truett Tate sold 18,861 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $3,461,182.11. Following the sale, the chief financial officer directly owned 259,512 shares of the company's stock, valued at approximately $47,623,047.12. This represents a 6.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Sanjay Gajendra sold 91,441 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,385,416 shares of company stock valued at $298,063,981. 12.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ALAB. Northland Capmk downgraded Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Northland Securities cut Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target on the stock. in a research note on Tuesday, July 22nd. Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Barclays reaffirmed an "overweight" rating and issued a $155.00 price target (up from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Finally, Zacks Research raised Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and a consensus target price of $129.13.

View Our Latest Stock Report on ALAB

Astera Labs Stock Up 0.9%

Shares of NASDAQ ALAB traded up $1.56 during trading on Friday, reaching $179.09. The company had a trading volume of 3,999,616 shares, compared to its average volume of 6,471,490. Astera Labs, Inc. has a 12-month low of $36.85 and a 12-month high of $199.47. The stock has a market cap of $29.77 billion, a PE ratio of 319.80, a P/E/G ratio of 4.54 and a beta of 1.39. The business's 50-day moving average is $123.97 and its 200 day moving average is $92.82.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. During the same period in the prior year, the firm posted $0.13 earnings per share. The company's quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Further Reading

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines